Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1997-1-30
|
pubmed:abstractText |
Cervical-cancer screening programmes using cytomorphological criteria could be more efficient if the screening included objective individual risk factors for women with normal cytology, such as a test for high-risk human papillomavirus (HPV). The value of a PCR-based test for high-risk HPV types was studied in a cohort of 1622 women presenting in a routine triannual population-based screening programme. Women were included in the study when they had no previous history of cervical dysplasia; and their initial Pap smear was read as normal (Pap 1 or 2). The mean age of the women was 42 years (range 34-54 years) and mean follow-up time was 40 months (range 5-73 months). Women were referred for colposcopically directed biopsies if they had had 2 successive cervical smears read as Pap 3a (mild to moderate dyskaryosis) or one read as > or = Pap 3b (severe dyskaryosis). Women with histologically confirmed cervical intraepithelial neoplasia grade III (CIN III) were considered positive cases. All women were tested for 14 high-risk HPV genotypes. Of the 86 high-risk HPV-positive women, 6 developed CIN III, whereas only 1 of the 1536 HPV-negative women did. The women with normal Pap smears containing high-risk HPV genotypes were 116 times (95% CI, 13-990) more at risk of developing CIN III, in contrast to women without high-risk HPV. These results support the view that the interval between successive smears in cervical-cancer screening can be increased considerably for women with cytomorphologically normal and high-risk HPV-negative cervical smears as determined by PCR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
766-9
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:8980181-Adult,
pubmed-meshheading:8980181-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:8980181-Cohort Studies,
pubmed-meshheading:8980181-DNA, Viral,
pubmed-meshheading:8980181-Female,
pubmed-meshheading:8980181-Humans,
pubmed-meshheading:8980181-Mass Screening,
pubmed-meshheading:8980181-Middle Aged,
pubmed-meshheading:8980181-Neoplasm Staging,
pubmed-meshheading:8980181-Odds Ratio,
pubmed-meshheading:8980181-Papillomaviridae,
pubmed-meshheading:8980181-Papillomavirus Infections,
pubmed-meshheading:8980181-Polymerase Chain Reaction,
pubmed-meshheading:8980181-Risk Factors,
pubmed-meshheading:8980181-Tumor Virus Infections,
pubmed-meshheading:8980181-Uterine Cervical Neoplasms,
pubmed-meshheading:8980181-Vaginal Smears
|
pubmed:year |
1996
|
pubmed:articleTitle |
PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.
|
pubmed:affiliation |
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|